speb/financial-data huggingface dataset:
INDO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -122972.00
INDO cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -16700.00
INDO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -58016.00
INDO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -704262.00
INDO cash_flow (annual, 2025-12-31) — Change In Payable: -321424.00
INDO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -444396.00
INDO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1085259.00
INDO cash_flow (annual, 2025-12-31) — Change In Receivables: 1299.00
INDO cash_flow (annual, 2025-12-31) — Change In Tax Payable: -16700.00
INDO cash_flow (annual, 2025-12-31) — Change In Working Capital: -2290634.00
INDO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1299.00
INDO cash_flow (annual, 2025-12-31) — Changes In Cash: 885313.00
INDO balance_sheet (annual, 2025-12-31) — Common Stock: 39966.00
INDO balance_sheet (quarterly, 2025-12-31) — Common Stock: 39966.00
INDO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 19658520.00
INDO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 19658520.00
INDO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 6564186.00
INDO income_statement (annual, 2025-12-31) — Cost Of Revenue: 3137408.00
INDO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 228624.00
INDO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 228624.00
INDO balance_sheet (annual, 2025-12-31) — Current Assets: 7496247.00
INDO balance_sheet (quarterly, 2025-12-31) — Current Assets: 7496247.00
INDO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 554905.00
INDO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 554905.00
INDO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 554905.00
INDO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 554905.00
INDO balance_sheet (annual, 2025-12-31) — Current Liabilities: 1460364.00
INDO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1460364.00
INDO cash_flow (annual, 2025-12-31) — Depreciation: 1197961.00
INDO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1197961.00
INDO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1197961.00
INDO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 363932.00
INDO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 363932.00
INDO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -5099805.00
INDO balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 1383.00
INDO balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 1383.00
INDO income_statement (annual, 2025-12-31) — EBIT: -5400562.00
INDO income_statement (annual, 2025-12-31) — EBITDA: -4202601.00
INDO balance_sheet (annual, 2025-12-31) — Employee Benefits: 268908.00
INDO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 268908.00
INDO cash_flow (annual, 2025-12-31) — End Cash Position: 7379309.00
INDO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 6564186.00
INDO cash_flow (annual, 2025-12-31) — Free Cash Flow: -5479543.00
INDO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -214996.00
INDO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 293463.00
INDO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 106471.00
INDO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 106471.00
INDO income_statement (annual, 2025-12-31) — General And Administrative Expense: 3453484.00
INDO balance_sheet (annual, 2025-12-31) — Gross PPE: 36064683.00
INDO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 36064683.00
INDO income_statement (annual, 2025-12-31) — Gross Profit: -1124865.00
INDO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
INDO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
INDO balance_sheet (annual, 2025-12-31) — Inventory: 1083387.00
INDO balance_sheet (quarterly, 2025-12-31) — Inventory: 1083387.00
INDO balance_sheet (annual, 2025-12-31) — Invested Capital: 19658520.00
INDO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 19658520.00
INDO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -244021.00
INDO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 6564186.00
INDO balance_sheet (annual, 2025-12-31) — Leases: 323675.00
INDO balance_sheet (quarterly, 2025-12-31) — Leases: 323675.00
INDO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 279080.00
INDO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 279080.00
INDO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 279080.00
INDO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 279080.00
INDO balance_sheet (annual, 2025-12-31) — Long Term Provisions: 724572.00
INDO balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 724572.00
INDO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 147358.00
INDO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 147358.00
INDO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 6564186.00
INDO income_statement (annual, 2025-12-31) — Net Income: -5099805.00
INDO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -5099805.00
INDO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -5099805.00
INDO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -5099805.00
INDO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5099805.00
INDO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -5099805.00
INDO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -5099805.00
INDO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -199330.00
INDO balance_sheet (annual, 2025-12-31) — Net PPE: 11136352.00
INDO balance_sheet (quarterly, 2025-12-31) — Net PPE: 11136352.00
INDO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -44691.00
INDO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 19658520.00
INDO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 19658520.00
INDO balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 1226653.00
INDO balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 1226653.00
INDO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 839191.00
INDO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 839191.00
INDO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 268908.00
INDO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 268908.00
INDO balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 136933.00
INDO balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 136933.00
INDO income_statement (annual, 2025-12-31) — Normalized EBITDA: -4496064.00
INDO income_statement (annual, 2025-12-31) — Normalized Income: -5393268.00
INDO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -5434852.00
INDO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -13225.00
INDO income_statement (annual, 2025-12-31) — Operating Income: -5400562.00
INDO income_statement (annual, 2025-12-31) — Operating Revenue: 2012543.00
INDO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 14987474.00
INDO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 14987474.00
INDO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 18248.00
INDO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 18248.00
INDO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 106471.00
INDO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 106471.00
INDO income_statement (annual, 2025-12-31) — Other Gand A: 3453484.00
INDO income_statement (annual, 2025-12-31) — Other Income Expense: 300757.00
INDO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -51362.00
INDO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1920000.00
INDO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1920000.00
INDO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 7294.00
INDO balance_sheet (annual, 2025-12-31) — Other Properties: 2335170.00
INDO balance_sheet (quarterly, 2025-12-31) — Other Properties: 2335170.00
INDO balance_sheet (annual, 2025-12-31) — Other Receivables: 837123.00
INDO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 837123.00
INDO balance_sheet (annual, 2025-12-31) — Payables: 658587.00
INDO balance_sheet (quarterly, 2025-12-31) — Payables: 658587.00
INDO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 887211.00
INDO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 887211.00
INDO cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 201771.00
INDO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
INDO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
INDO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 405406.00
INDO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 405406.00
INDO income_statement (annual, 2025-12-31) — Pretax Income: -5099805.00
INDO balance_sheet (annual, 2025-12-31) — Properties: 33254168.00
INDO balance_sheet (quarterly, 2025-12-31) — Properties: 33254168.00
INDO income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 822213.00
INDO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 822213.00
INDO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -44691.00
INDO balance_sheet (annual, 2025-12-31) — Raw Materials: 1083387.00
INDO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1083387.00
INDO balance_sheet (annual, 2025-12-31) — Receivables: 548145.00
INDO balance_sheet (quarterly, 2025-12-31) — Receivables: 548145.00
INDO balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -632019.00
INDO balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -632019.00
INDO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3137408.00
INDO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1197961.00
INDO balance_sheet (annual, 2025-12-31) — Retained Earnings: -51026783.00
INDO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -51026783.00
INDO income_statement (annual, 2025-12-31) — Selling General And Administration: 3453484.00
INDO balance_sheet (annual, 2025-12-31) — Share Issued: 14987474.00
INDO balance_sheet (quarterly, 2025-12-31) — Share Issued: 14987474.00
INDO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 0.00
INDO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 19658520.00
INDO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 19658520.00
INDO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 19658520.00
INDO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 19658520.00
INDO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
INDO income_statement (annual, 2025-12-31) — Tax Provision: 0.00
INDO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
INDO balance_sheet (annual, 2025-12-31) — Total Assets: 22755376.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Assets: 22755376.00
INDO balance_sheet (annual, 2025-12-31) — Total Capitalization: 19658520.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 19658520.00
INDO balance_sheet (annual, 2025-12-31) — Total Debt: 833985.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Debt: 833985.00
INDO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 19658520.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 19658520.00
INDO income_statement (annual, 2025-12-31) — Total Expenses: 7413105.00
INDO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3096856.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3096856.00
INDO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 15259129.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 15259129.00
INDO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1636492.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1636492.00
INDO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -4578349.00
INDO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 60986.00
INDO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 60986.00
INDO income_statement (annual, 2025-12-31) — Total Unusual Items: 293463.00
INDO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 293463.00
INDO balance_sheet (annual, 2025-12-31) — Working Capital: 6035883.00
INDO balance_sheet (quarterly, 2025-12-31) — Working Capital: 6035883.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — +Operating Expense: 1479246000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — +Total Revenue: 7790952000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 1260913000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 1672610000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1290618000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 291542000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -12968000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Amortization: 52803000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 52803000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 907000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 70697853.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Basic EPS: 3.26
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 151603000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 596091000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -397299000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 353488000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 61665000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 61665000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -21209000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 61665000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -348297000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: 103102000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 73196000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Change In Payable: 223724000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -399708000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -351678000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 85339000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Common Stock: 353488000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -21209000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 1874949000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 224566000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 5885460000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Current Assets: 3403348000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Current Debt: 1566440000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 1566440000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 20262000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 3144266000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 235850000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Depreciation: 88055000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 140858000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 140858000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 88055000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 70697853.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Diluted EPS: 3.26
INDOAMIN.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 230475000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 11178000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 108000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — EBIT: 463650000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — EBITDA: 604508000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — End Cash Position: 236943000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 319151000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 543488000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Fixed Assets Revaluation Reserve: 13938000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -242712000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -844000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 90377000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Goodwill: 125704000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 150131000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1685578000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 3187814000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Gross Profit: 1905492000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Interest Expense: 118501000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 118501000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Interest Income: 6684000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 6684000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -139728000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 6684000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Inventory: 1226705000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 3947613000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -388399000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 907000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 737604000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 217480000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 506224000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 506224000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 313767000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -257515000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 14080000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 2090561000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 2053000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Net Debt: 2010999000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Income: 230475000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 230475000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 230475000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 230475000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 230475000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 345149000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 230475000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Interest Income: -133045000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 0.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 480089000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 56252000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -133045000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -1000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Net PPE: 1897196000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -395191000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 423837000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 1724818000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 447000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1171000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 5961000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 76053000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 600621000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Normalized Income: 227879435.98
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 154587000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Operating Income: 426246000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Operating Revenue: 7790952000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 70697560.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 265685000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 10966000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 1521461000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 24427000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 29266000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 129079000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 53903000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 2000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 7146000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 269087000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Payable: 11207000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Properties: 59116000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 108031000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Other Special Charges: -736000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Payables: 1283298000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8102000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 34625000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Pretax Income: 345149000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 3226000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -397299000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 443452000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 5885460000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 140858000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -257515000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Research And Development: 7604000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 175278000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 0.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1192890000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 2108000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 590088000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 680465000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Share Issued: 70697560.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 423837000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Special Income Charges: 3887000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 1874949000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 1724818000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 1291435.98
INDOAMIN.NS income_statement (annual, 2022-03-31) — Tax Provision: 114674000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.33
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 124434000.00
INDOAMIN.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -111203000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Assets: 5544612000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 2381173000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Debt: 2072664000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 1877002000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Total Expenses: 7364706000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 3667610000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 2141263000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 523344000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 21228000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 20262000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 3887000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 3887000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 1257682000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Trading Securities: 0.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Work In Process: 210499000.00
INDOAMIN.NS balance_sheet (annual, 2022-03-31) — Working Capital: 259082000.00
INDOAMIN.NS income_statement (annual, 2022-03-31) — Write Off: -3151000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1564673000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — +Total Revenue: 9412422000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1042739000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1874352000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1404371000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -13868000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Amortization: 54788000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 54788000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 2557000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 70720761.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Basic EPS: 5.78
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 236943000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 625514000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -313380000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 353488000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 59721000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 60733000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -35349000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 59721000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -130138000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -20596000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -19583000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Change In Payable: -219273000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -202520000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -592697000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -54385000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Common Stock: 353488000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -35349000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2253700000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 205024000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 7108510000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Current Assets: 3726455000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1739711000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1739711000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 33741000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 3091610000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 187777000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Depreciation: 118342000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 173130000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 173130000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 118342000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 70720761.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Diluted EPS: 5.78
INDOAMIN.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 408766000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 11722000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 3000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — EBIT: 716973000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — EBITDA: 890103000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — End Cash Position: 182559000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 40264000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 496653000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -109755000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -430000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 119715000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 105627000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1888220000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 3481937000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Gross Profit: 2303912000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Interest Expense: 149075000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 149075000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Interest Income: 7630000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 7630000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -172382000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 7630000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Inventory: 1356843000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 4574359000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -298274000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 2557000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 247995000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 220007000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 580948000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 580948000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 74724000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: 0.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 11704000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2356056000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 4438000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2260938000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -18177000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Income: 408766000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 408766000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 408766000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 408766000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 408766000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 567898000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 408766000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Interest Income: -164752000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 2662000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 247995000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 74724000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -164752000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2077566000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -308568000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 173271000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2148073000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 28819000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 11704000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 60772000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 891148000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Normalized Income: 409518178.16
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 203625000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Operating Income: 739239000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Operating Revenue: 9412422000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 70697560.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 309505000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 10755000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 1900212000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 22336000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 28354000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 164758000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 34853000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -2000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 21508000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 295655000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Payable: 10702000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Properties: 75336000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 79300000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1012000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Other Special Charges: -427000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Payables: 1065163000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6691000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 50527000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Pretax Income: 567898000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 2008000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -313380000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 638879000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 7108510000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 173130000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Research And Development: 9714000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 122838000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 4812000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 447175000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 566890000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Share Issued: 70697560.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 173271000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: 0.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Special Income Charges: -260000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2253700000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2148073000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -292821.84
INDOAMIN.NS income_statement (annual, 2023-03-31) — Tax Provision: 159132000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.28
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 181862000.00
INDOAMIN.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -92868000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Assets: 5972977000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 2834648000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Debt: 2320659000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2258138000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Total Expenses: 8673183000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3714839000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2246522000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 623229000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 23307000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 33741000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -1045000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -1045000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 1038409000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Trading Securities: 0.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Work In Process: 192957000.00
INDOAMIN.NS balance_sheet (annual, 2023-03-31) — Working Capital: 634845000.00
INDOAMIN.NS income_statement (annual, 2023-03-31) — Write Off: 687000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — +Operating Expense: 1521112000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — +Total Revenue: 9434575000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1179911000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2177966000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1537785000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 292487000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -21045000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Amortization: 15473000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 15473000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 5707000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 72205743.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Basic EPS: 5.92
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 182559000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 658938000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -307683000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 362938000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 38315000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 56076000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -35349000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 38315000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 216354000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -111793000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -8300000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Change In Payable: 137011000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -299527000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -84397000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 22550000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Common Stock: 362938000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -35349000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2646765000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 225845000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 7202368000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Current Assets: 3961138000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1572792000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1572792000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 18806000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 3035205000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 187012000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Depreciation: 137186000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 152659000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 152660000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 137187000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 72205743.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Diluted EPS: 5.92
INDOAMIN.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 427458000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 10729000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 80000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — EBIT: 786145000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — EBITDA: 938805000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — End Cash Position: 205109000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -408697000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 439519000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 391206000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -22558000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 124235000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 156519000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2199010000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3695754000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Gross Profit: 2195797000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Interest Expense: 203540000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 203540000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Interest Income: 9099000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 9099000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -222449000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 9072000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Inventory: 1140680000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 4816624000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -267642000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 5707000.00